Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - SYNERGY PHARMACEUTICALS, INC.sgyp-ex322x33118x10q.htm
EX-31.2 - EXHIBIT 31.2 - SYNERGY PHARMACEUTICALS, INC.sgyp-ex312x33118x10q.htm
EX-31.1 - EXHIBIT 31.1 - SYNERGY PHARMACEUTICALS, INC.sgyp-ex311x33118x10q.htm
10-Q - 10-Q - SYNERGY PHARMACEUTICALS, INC.sgyp-33118x10q.htm


EXHIBIT 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER

SYNERGY PHARMACEUTICALS INC.

FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2018

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
I am the Chief Executive Officer of Synergy Pharmaceuticals Inc., a Delaware corporation (the “Company”). I am delivering this certificate in connection with the Form 10-Q of the Company for the quarter ended March 31, 2018 and filed with the Securities and Exchange Commission (“Form 10-Q”).
 
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date:
May 10, 2018
/s/ TROY HAMILTON
 
 
Troy Hamilton
 
 
Chief Executive Officer